Bifidobacterium catenulatum

Bifidobacterium catenulatum is a probiotic strain that produces short-chain fatty acids (SCFAs) and bacteriocins to support gut health. This beneficial bacteria enhances intestinal barrier function and modulates immune responses through interactions with intestinal epithelial cells.

Origin & History

Bifidobacterium catenulatum is a probiotic strain commonly found in the human gut microbiota and some fermented foods. It is recognized for its role in maintaining intestinal health.

Historical & Cultural Context

Traditionally found in fermented foods, Bifidobacterium catenulatum has been valued for its digestive health benefits.

Health Benefits

- Supports a balanced gut microbiota by promoting the growth of beneficial bacteria, which can improve digestion and nutrient absorption. - Enhances immune system function by stimulating the production of antibodies, reducing the risk of infections. - May reduce symptoms of gastrointestinal disorders like IBS by modulating gut inflammation, leading to improved comfort. - Aids in lowering cholesterol levels by binding to bile acids, which can reduce heart disease risk. - Contributes to weight management by increasing satiety hormones, helping control appetite. - Improves mental health by producing neurotransmitters like serotonin, which can elevate mood. - Supports skin health by reducing systemic inflammation, leading to clearer skin.

How It Works

Bifidobacterium catenulatum produces short-chain fatty acids like acetate and lactate through carbohydrate fermentation, which lower intestinal pH and inhibit pathogenic bacteria growth. The strain synthesizes bacteriocins and other antimicrobial compounds that directly suppress harmful microorganisms. It also stimulates toll-like receptor signaling pathways in intestinal epithelial cells, promoting mucin production and strengthening tight junction proteins.

Scientific Research

Emerging research indicates Bifidobacterium catenulatum may support gut health and immune function, but further studies are required.

Clinical Summary

Research on Bifidobacterium catenulatum is primarily based on in vitro studies and small human trials with 20-50 participants. Studies show potential improvements in lactose digestion and reduction in inflammatory markers like TNF-α and IL-6. A 4-week trial with 40 adults demonstrated modest improvements in bowel movement frequency and stool consistency. However, large-scale randomized controlled trials are needed to establish definitive clinical efficacy and optimal dosing protocols.

Nutritional Profile

- Contains live probiotic cultures. - Produces lactic acid, aiding digestion. - Low in calories.

Preparation & Dosage

Available in probiotic supplements and some fermented foods. Dosage varies; consult a healthcare provider.

Synergy & Pairings

Inulin, Fructooligosaccharides, Lactobacillus rhamnosus

Safety & Interactions

Bifidobacterium catenulatum is generally well-tolerated with minimal side effects, though mild bloating or gas may occur during initial supplementation. Immunocompromised individuals should consult healthcare providers before use due to rare cases of bacteremia with probiotic strains. No significant drug interactions have been reported, but antibiotics may reduce probiotic effectiveness. Safety during pregnancy and breastfeeding has not been established through controlled studies.